Patent details
EP1919477 Title: Use of Ö2-(2-methylimidazol-1-yl)methylÜpyridine for treating sleep disorders
Basic Information
- Publication number:
- EP1919477
- PCT Application Number:
- PCT/US/2006/029112
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP067747006
- PCT Publication Number:
- WO/2007/016203
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Use of Ö2-(2-methylimidazol-1-yl)methylÜpyridine for treating sleep disorders
- French Title of Invention:
- Utilisation du Ö2-(2-methylimidazol-1-yl)methylÜpyridine pour le traitement des troubles du sommeil
- German Title of Invention:
- Verwendung von Ö2-(2-methylimidazol-1-yl)methylÜpyridin zur Behandlung von Schlafstörungen
- SPC Number:
Dates
- Filing date:
- 26/07/2006
- Grant date:
- 11/07/2012
- EP Publication Date:
- 11/07/2012
- PCT Publication Date:
- 08/02/2007
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/05/2008
- EP B1 Publication Date:
- 11/07/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/07/2012
- Expiration date:
- 26/07/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/07/2006
- Name:
- Vanda Pharmaceuticals Inc.
- Address:
- 9620 Medical Center Drive, Rockville, MD 20850, United States (US)
Inventor
1
- Name:
- POLYMEROPOULOS Mihael, H.
- Address:
- United States (US)
2
- Name:
- LAVEDAN Christian, N.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 703604 P
- Priority Date:
- 29/07/2005
- Priority Country:
- United States (US)
2
- Priority Number:
- 732536 P
- Priority Date:
- 02/11/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/44;
| Filing date | Document type | Number of pages |
|---|